SON-1010 is being studied as a combination therapy with trabectedin (Yondelis®), the first FDA-approved treatment for two types of advanced soft tissue sarcoma after failure of standard chemotherapy, ...

RFK Jr., the nation’s new health secretary, has cited “highly chemically processed foods” as a chief culprit behind an ...

Related Marijuana users at greater risk for heart attack, stroke Wealthier Americans face lower risk of heart disease Butter a deadly delight compared to plant oils, study says This combination ...

The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...

Dr. Manideep Gopishetty is a distinguished physician-entrepreneur based in Saskatoon, Saskatchewan, who stands at the ...

A new study reveals that IL-12, an inflammatory molecule, accelerates Alzheimer’s disease by damaging brain cells and preventing plaque clearance. Blocking IL-12 in mice halted disease-related changes ...

Biomea Fusion (BMEA) announced the presentation of preclinical and clinical data from studies assessing icovamenib at the Advanced Technologies ...

As law firms face the decline of the billable hour, this article explores how they must rethink incentive structures, with ...

A new study from Auburn University provides new insights into neuronal connections, offering hope for the treatment of ...

“This study confirms that combined cholesterol lowering therapy should be considered immediately and should be the gold ...

Researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center have detailed the precise mechanism through which the inflammatory ... published in "Nature Aging," could pave the way ...

Antibiotic-resistant bacteria are a serious public health threat. Understanding the biology of these bacteria—such as how ...